Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

Share Price is delayed by 15 minutes
Get Live Data
778.50    -6.00 (-0.76%)
Bid:
778.00
Ask:
779.00
Spread: 1.00 (0.129%)
Market Cap: £2.62b
DRX Live PriceLast checked at - London Stock Exchange

Intraday Drax Share Chart

Share Buyback Programme

22 Oct 2024 07:00

RNS Number : 0313J
Drax Group PLC
22 October 2024
 

22 October 2024

 

DRAX GROUP PLC

(Symbol: DRX)

 

Share Buyback Programme

 

On 7 August 2024, Drax Group plc (the "Company") announced that in connection with the up to £300 million share buyback programme announced on 26 July 2024 (the "Programme"), it was commencing the first tranche of a share buyback programme to purchase ordinary shares of 11 16/29 pence each in the Company up to a maximum consideration of £75 million (the "First Tranche"). As at 21 October 2024, the Company had repurchased 9,031,476 shares for a consideration of c.£59 million. The First Tranche of the Programme is therefore over 75% completed.

 

The Company is today confirming that the second tranche of the Programme to purchase ordinary shares in the Company of up to a maximum consideration of £75 million (the "Second Tranche") will commence immediately following the conclusion of the First Tranche.

 

The purpose of the Second Tranche is to reduce the Company's share capital. The ordinary shares purchased by the Company will be held in treasury pending cancellation or re-issue.

 

Ordinary share purchases as part of the Second Tranche of the Programme will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volumes. The maximum number of shares that may be repurchased by the Company under the Second Tranche of the Programme is 29,436,781, being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the AGM on 25 April 2024 less the shares acquired under the First Tranche. The Company expects the required authority will be renewed at the AGM to be held in 2025.

 

The Company has entered into a non-discretionary agreement with RBC Europe Limited ("RBC") pursuant to which it has issued irrevocable instructions to RBC to conduct the Second Tranche of the Programme. RBC will carry out the Second Tranche of the Programme through the acquisition of ordinary shares in the Company within certain pre-defined parameters for subsequent repurchase by the Company. Any purchase of ordinary shares in the Company will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (EU) 2016/1052 (also as in force in the UK, from time to time, including, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the Market Abuse (Amendment) (EU Exit) Regulations 2019) as well as applicable laws and the regulations of the UK Financial Conduct Authority (including Chapter 9 of the UK Listing Rules).

 

The Company will make further announcements in due course following the buyback of shares. Note there is no guarantee that the Programme will be implemented in full.

 

Capitalised terms relate to the Company's announcement on 7 August 2024 unless specified otherwise.

 

Enquiries:

Drax Investor Relations: Mark Strafford

+44 (0) 7730 763 949

 

Media:

Drax External Communications: Andy Low

+44 (0) 7841 068415 

 

RBC Europe Limited:

James Agnew / Jack Wood

+44 (0) 20 7404 5959

 

Website: www.drax.com

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZMZGLMVGDZM
Date   Source Headline
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20263:22 pmRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 202611:41 amRNSDirectorate Change & Company Secretary Appointment
2nd Mar 202611:39 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20263:25 pmRNSDividend Declaration
26th Feb 20267:00 amRNSAnnual Financial Report
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTolling agreement for 200MW (800MWh) of BESS
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202610:13 amRNSNotice of Results
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSDirectorate change
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20262:03 pmRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTolling agreement for 250MW (500MWh) of BESS
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 202610:33 amRNSHolding(s) in Company
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20264:17 pmRNSHolding(s) in Company
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSAcquisition of Asset Optimisation Platform
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.